Finally, from a translational perspective, since the APC “gatekeeping” gene is a key regulator of Wnt signaling and ~90% of all colon cancer cases are associated with defects in the Wnt signaling pathway, our observations support the development of plasma membrane-targeted therapies to reduce cancer risk. This evidence concerns the gene APC and malignant colon neoplasm.